News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avita Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Avita tumbles 16pc as RECELL study results disappoint investors
News
Market Highlights: Wall St fades, a BTC rally, 5 ASX small caps to watch on Friday
News
Closing Bell: Mrs Pelosi goes to Taipei; Pfizer comes back for ResApp
News
ASX Small Caps Lunch Wrap: Who else is up to some serious monkey business today?
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
Experts
Morningstar confident of healthcare recovery as sector outperforms ASX 200 in Q3
News
ASX Small Caps Lunch Wrap: Who else reckons Elon Musk is doing things the hard way?
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Health & Biotech
ASX Health Stocks: Avita to start selling RECELL across the US to treat extensive burns
News
ASX Small Cap Lunch Wrap: Who’s hacking the hackers today?
Health & Biotech
ASX Health Stocks: Cannabis biotech Avecho begins dosing patients in CBD gel study to treat osteoarthritis
Health & Biotech
ASX Health Stocks: Polynovo jumps 18pc with record US sales in December
News
Market Highlights and 5 ASX Small Caps to watch on Friday
News
These are 8 ASX stocks currently trading at 12-month highs (and lows)
Health & Biotech
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval
Health & Biotech
ASX Health Stocks: Osprey jumps 8% on solid first half; Bard1 concludes successful study
News